Skip to main content

Table 2 Planned variables to be extracted in the scoping review

From: Personal goal-setting among women living with breast cancer: protocol for a scoping review

General study details Study ID number, lead author, title, journal, year of publication, type of publication, information source, primary and secondary purposes
Study characteristics Study design, study duration, pilot/feasibility study (y/n), number of study arms, covariates (definition and measurement methods)
Participants  • Total number, setting, inclusion and exclusion criteria
 • Participant characteristics at baseline: for each study, average age (years, mean and standard deviation [SD]), sex (%), country, cancer treatment received, breast cancer treatment stage, time since diagnosis (or time since treatment, if treatment was completed)
 • If available: breast cancer stage, race or ethnicity, socioeconomic status
Interventions/exposures and comparators  • Total number of intervention/exposure and comparison groups, number of participants in each group
 • For each intervention/exposure and comparison group: justification for goal-setting, type of goal setting used (BCT), materials and procedures used, who administered the intervention/exposure/comparison, training to deliver goal-setting, mode of delivery, location, timing of delivery, duration of intervention/exposure, any tailoring of the intervention, any modifications, techniques to support goal pursuit, co-interventions (if any), intervention adherence or fidelity—who and how assessed, and results of assessment
 • For each intervention/exposure: participant involvement in personal goal-setting, new or existing goals identified, any parameters given for goal-setting.
 • For each comparison (if applicable): whether personal goal-setting was part of the intervention, participant involvement (if any) if goals were set
Instruments used in goal-setting Type of instrument used, construct validity (if reported), concurrent validity (if reported), validated with women with breast cancer, feasibility (if reported)
Outcomes  • List of outcomes and time points (a) collected, (b) reported. Identification of study’s primary outcome
 • Data collection method: quantitative or qualitative
 • For each outcome: outcome definition (narrative plus name of scale or diagnostic method)
 • For scales: validity, upper and lower limits, direction of benefit
Results For each quantitative outcome: sample size, number of missing participants, reasons for loss to follow up, summary data for each group (2 × 2 table for dichotomous data, means and SDs for continuous data), estimate of effect for difference between groups (or change in baseline and final scores for single-arm studies), confidence intervals, p value